Schulz, Stefan; Jesinghaus, Moritz; Foersch, Sebastian
Artificial intelligence in diagnostics-a pathology perspectivePATHOLOGIE. 2025
Kelm, Nicolas; Kespohl, Meike; Smagurauskaite, Gintare et al.
Assessing customized multivalent chemokine-binding peptide treatment in a murine model of coxsackievirus B3 myocarditisBASIC RESEARCH IN CARDIOLOGY. 2025
Gustav, Marco; van Treeck, Marko; Reitsam, Nic G. et al.
Assessing genotype-phenotype correlations in colorectal cancer with deep learning: a multicentre cohort studyLANCET DIGITAL HEALTH. Bd. 7. H. 8. 2025
Buhr, Christoph Raphael; Ernst, Benjamin Philipp; Blaikie, Andrew et al.
Assessment of decision-making with locally run and web-based large language models versus human board recommendations in otorhinolaryngology, head and neck surgeryEUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2025
Neidlinger, Peter; El Nahhas, Omar S. M.; Muti, Hannah Sophie et al.
Benchmarking foundation models as feature extractors for weakly supervised computational pathologyNATURE BIOMEDICAL ENGINEERING. 2025
Kechagioglou, Petros; Yurugi, Hajime; Dupont, Camille et al.
CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responsesISCIENCE. Bd. 28. H. 6. 2025
Madsen, Peter J.; Schlitter, Anna Melissa; Flemmig, Carina et al.
Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumorsJOURNAL FOR IMMUNOTHERAPY OF CANCER. Bd. 13. H. 10. 2025
Wilgenbus, Petra; Pott, Jennifer; Pagel, Sven et al.
Coagulation proteases modulate nucleic acid uptake and cGAS-STING-IFN induction in the tumor microenvironmentJCI INSIGHT. Bd. 10. H. 17. 2025
Moehler, Markus; Yoon, Harry H.; Wagner, Daniel-Christoph et al.
Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With TislelizumabMODERN PATHOLOGY. Bd. 38. H. 9. 2025
Kolb, Antonia; Kulis-Mandic, Ana-Marija; Klein, Matthias et al.
Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistanceNATURE COMMUNICATIONS. Bd. 16. H. 1. 2025